Neuroendocrine and viral correlates of premature immunosenescence

Annals of the New York Academy of Sciences

Volumn 1351, Issue 1, 2015, Pages 11-21

  Bauer, Moisés E ^a   Wieck, Andrea ^a   Petersen, Laura E ^a   Baptista, Talita S A ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Aging; Cytomegalovirus; Glucocorticoids; Immunosenescence; Lymphocytes; Psychological stress

Indexed keywords

BIOLOGICAL MARKER; CD28 ANTIGEN; HYDROCORTISONE; IMMUNOGLOBULIN G ANTIBODY; T LYMPHOCYTE RECEPTOR; GLUCOCORTICOID; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIBODY TITER; ARTICLE; BIPOLAR DISORDER; CD8+ T LYMPHOCYTE; CELL AGING; CELL EXPANSION; CHRONIC INFLAMMATION; CHRONIC STRESS; CLINICAL FEATURE; CLONAL VARIATION; COGNITIVE DEFECT; CYTOMEGALOVIRUS INFECTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNITY; INFLAMMATION; INVOLUTION; LYMPHOCYTE PROLIFERATION; MENTAL STRESS; MORTALITY; NEUROENDOCRINE SYSTEM; NONHUMAN; PREMATURE AGING; PREMATURE IMMUNOSENESCENCE; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SENESCENCE; TELOMERE SHORTENING; VIRUS INFECTION; VIRUS LOAD; CENTRAL NERVOUS SYSTEM INFECTION; CYTOMEGALOVIRUS; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; IMMUNOSENESCENCE; LYMPHOCYTE ACTIVATION; METABOLISM; NEUROSECRETION; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE; VIROLOGY;

ARTHRITIS, RHEUMATOID; BIPOLAR DISORDER; CELL AGING; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOSENESCENCE; INFLAMMATION; LYMPHOCYTE ACTIVATION; NEUROSECRETORY SYSTEMS; PITUITARY-ADRENAL SYSTEM; RECEPTORS, ANTIGEN, T-CELL; STRESS, PSYCHOLOGICAL; T-LYMPHOCYTES;

EID: 84942079490     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12786     Document Type: Article

References (75)

1. Fulop, T., A. Larbi & G. Pawelec 2013. Human T cell aging and the impact of persistent viral infections. Front. Immunol. 4: 271.
2. Camous, X. et al. 2012. NK cells in healthy aging and age-associated diseases. J. Biomed. Biotechnol. 2012: 195956.
3. Ortega, E., J.J. Garcia & M. De La Fuente 2000. Ageing modulates some aspects of the non-specific immune response of murine macrophages and lymphocytes. Exp. Physiol. 85: 519-525.
4. Shaw, A.C., D.R. Goldstein & R.R. Montgomery 2013. Age-dependent dysregulation of innate immunity. Nat. Rev. Immunol. 13: 875-887.
5. Ortega, E. et al. 2012. Hsp72, inflammation, and aging: causes, consequences, and perspectives. Ann. N.Y. Acad. Sci. 1261: 64-71.
6. De la Fuente, M. et al. 2011. Strategies to improve the functions and redox state of the immune system in aged subjects. Curr. Pharm. Des. 17: 3966-3993.
7. Franceschi, C. et al. 2000. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 908: 244-254.
8. Licastro, F. et al. 2005. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun. Ageing. 2: 8.
9. Palmer, D.B. 2013. The effect of age on thymic function. Front. Immunol. 4: 316.
10. Nikolich-Zugich, J. 2014. Aging of the T cell compartment in mice and humans: from no naive expectations to foggy memories. J. Immunol. 193: 2622-2629.
11. Luz, C. et al. 2003. Impact of psychological and endocrine factors on cytokine production of healthy elderly people. Mech. Ageing Dev. 124: 887-895.
12. Luz, C. et al. 2006. Healthy aging is associated with unaltered production of immunoreactive growth hormone but impaired neuroimmunomodulation. Neuroimmunomodulation 13: 160-169.
13. Bauer, M.E., C.M. Jeckel & C. Luz 2009. The role of stress factors during aging of the immune system. Ann. N.Y. Acad. Sci. 1153: 139-152.
14. Bauer, M.E. et al. 2000. Chronic stress in caregivers of dementia patients is associated with reduced lymphocyte sensitivity to glucocorticoids. J. Neuroimmunol. 103: 84-92.
15. Redinbaugh, E.M., R.C. MacCallum & J.K. Kiecolt-Glaser 1995. Recurrent syndromal depression in caregivers. Psychol. Aging 10: 358-368.
16. Schulz, R. & S.R. Beach 1999. Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA 282: 2215-2219.
17. Glaser, R. & J.K. Kiecolt-Glaser 2005. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 5: 243-251.
18. Bauer, M.E. 2008. Chronic stress and immunosenescence: a review. Neuroimmunomodulation 15: 241-250.
19. Vedhara, K. et al. 1999. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 353: 627-631.
20. Glaser, R. et al. 2000. Chronic stress modulates the immune response to a pneumococcal pneumonia vaccine. Psychosom. Med. 62: 804-807.
21. Esterling, B.A., J.K. Kiecolt-Glaser & R. Glaser 1996. Psychosocial modulation of cytokine-induced natural killer cell activity in older adults. Psychosom. Med. 58: 264-272.
22. Damjanovic, A.K. et al. 2007. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J. Immunol. 179: 4249-4254.
23. Kiecolt-Glaser, J.K. et al. 2003. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. U.S.A. 100: 9090-9095.
24. Bierhaus, A. et al. 2003. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. U.S.A. 100: 1920-1925.
25. Miller, G.E. et al. 2008. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol. Psychiatry 64: 266-272.
26. Harris, T.B. et al. 1999. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106: 506-512.
27. Epel, E.S. et al. 2004. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. U.S.A. 101: 17312-17315.
28. Badami, K.G. et al. 2009. Cytomegalovirus seroprevalence and 'cytomegalovirus-safe' seropositive blood donors. Epidemiol. Infect. 137: 1776-1780.
29. Betjes, M.G., N.H. Litjens & R. Zietse 2007. Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol. Dial. Transplant. 22: 3298-3303.
30. Lawlor, G. & A.C. Moss 2010. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm. Bowel Dis. 16: 1620-1627.
31. + T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J. Virol. 79: 3675-3683.
32. Acuto, O. & F. Michel 2003. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3: 939-951.
33. Effros, R.B., Z. Cai & P.J. Linton 2003. CD8 T cells and aging. Crit. Rev. Immunol. 23: 45-64.
34. Vallejo, A.N. 2005. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol. Rev. 205: 158-169.
35. + T-cell replicative senescence in human aging. Immunol. Rev. 205: 147-157.
36. + T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202: 673-685.
37. Trzonkowski, P. et al. 2003. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine 21: 3826-3836.
38. Hadrup, S.R. et al. 2006. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176: 2645-2653.
39. Bentz, G.L. & A.D. Yurochko 2008. Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proc. Natl. Acad. Sci. U.S.A. 105: 5531-5536.
40. Chen, S. et al. 2012. Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study. Immun. Ageing 9: 18.
41. Wikby, A. et al. 2005. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J. Gerontol. A Biol. Sci. Med. Sci. 60: 556-565.
42. Luz Correa, B. et al. 2014. The inverted CD4:CD8 ratio is associated with cytomegalovirus, poor cognitive and functional states in older adults. Neuroimmunomodulation 21: 206-212.
43. Strindhall, J. et al. 2013. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age 35: 985-991.
44. Wang, G.C. et al. 2010. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am. J. Epidemiol. 171: 1144-1152.
45. Goronzy, J.J., L. Shao & C.M. Weyand 2010. Immune aging and rheumatoid arthritis. Rheum. Dis. Clin. North Am. 36: 297-310.
46. Petersen, L.E. et al. 2015. Premature immunosenescence is associated with memory dysfunction in rheumatoid arthritis. Neuroimmunomodulation 22: 130-137.
47. Bryl, E. et al. 2001. Down-regulation of CD28 expression by TNF-alpha. J. Immunol. 167: 3231-3238.
48. Weyand, C.M., Z. Yang & J.J. Goronzy 2014. T-cell aging in rheumatoid arthritis. Curr. Opin. Rheumatol. 26: 93-100.
49. Colmegna, I. et al. 2008. Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum. 58: 990-1000.
50. Wagner, U.G. et al. 1998. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 95: 14447-14452.
51. Steer, S.E. et al. 2007. Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration. Ann. Rheum. Dis. 66: 476-480.
52. Fujii, H. et al. 2009. Telomerase insufficiency in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 106: 4360-4365.
53. Kleyer, A. & G. Schett 2014. Arthritis and bone loss: a hen and egg story. Curr. Opin. Rheumatol. 26: 80-84.
54. - T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 109: 2744-2748.
55. Rizzo, L.B. et al. 2014. The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research. Neurosci. Biobehav. Rev. 42: 157-169.
56. Hallahan, B. et al. 2011. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol. Psychiatry 69: 326-335.
57. Martinez-Aran, A. et al. 2007. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 9: 103-113.
58. Martinez-Aran, A. et al. 2005. Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother. Psychosom. 74: 295-302.
59. Fernandes, B.S. et al. 2011. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J. Psychiatr. Res. 45: 995-1004.
60. Brietzke, E. et al. 2009. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J. Affect. Disord. 116: 214-217.
61. Modabbernia, A. et al. 2013. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol. Psychiatry 74: 15-25.
62. Barbosa, I.G. et al. 2013. Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients. J. Psychiatr. Res. 47: 1949-1954.
63. do Prado, C.H. et al. 2013. Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder. Psychoneuroendocrinology 38: 667-676.
64. Wieck, A. et al. 2013. Differential neuroendocrine and immune responses to acute psychosocial stress in women with type 1 bipolar disorder. Brain Behav. Immun. 34: 47-55.
65. Miller, C. & M.S. Bauer 2014. Excess mortality in bipolar disorders. Curr. Psychiatr. Rep. 16: 499.
66. Rizzo, L.B. et al. 2013. Immunosenescence is associated with human cytomegalovirus and shortened telomeres in type I bipolar disorder. Bipolar Disord. 15: 832-838.
67. Yurochko, A.D. et al. 1997. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J. Virol. 71: 5051-5059.
68. Girshkin, L. et al. 2014. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology 49: 187-206.
69. Dettenborn, L. et al. 2012. Introducing a novel method to assess cumulative steroid concentrations: increased hair cortisol concentrations over 6 months in medicated patients with depression. Stress 15: 348-353.
70. Carpenter, L.L. et al. 2009. Effect of childhood emotional abuse and age on cortisol responsivity in adulthood. Biol. Psychiatry 66: 69-75.
71. MacMillan, H.L. et al. 2009. Cortisol response to stress in female youths exposed to childhood maltreatment: results of the youth mood project. Biol. Psychiatry 66: 62-68.
72. Burke, H.M. et al. 2005. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 30: 846-856.
73. Lennartsson, A.K. et al. 2015. Burnout and hypocortisolism-a matter of severity? A study on ACTH and cortisol responses to acute psychosocial stress. Front. Psychiatry 6: 8.
74. Raison, C.L. et al. 2013. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70: 31-41.
75. Bauer, M.E. et al. 2013. Psychoneuroendocrine interventions aimed at attenuating immunosenescence: a review. Biogerontology 14: 9-20.